Condition

Epilepsy, Drug Resistant clinical trials and research

As of November 12, 2026, Find a Trial lists 3 Epilepsy, Drug Resistant clinical trials that are recruiting, at sites in 2 countries (most in China (2), United States (1)). By phase: Early Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest Epilepsy, Drug Resistant clinical trials

StudyPhaseWhereStatusRegistered
Non-Invasive Low Intensity Focused Ultrasound Stimulation for Drug-Resistant Epilepsy — San Francisco, California Recruiting Jul 2, 2026
Using sirolimus to treat drug-resistant focal epilepsy Early Phase 1 Beijing Recruiting Dec 6, 2024
Electrical stimulation of the subthalamic nucleus for drug-resistant focal motor epilepsy — Beijing, Beijing Municipality Recruiting Feb 8, 2024

All recruiting trials (3)

Related topics

Drug Resistant EpilepsyEpilepsyEpilepsy, GeneralizedEpilepsy (Treatment Refractory)

Quick answers

How many Epilepsy, Drug Resistant clinical trials are recruiting right now?

3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 2 countries. The most sites are in China (2 trials), United States (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Early Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.